Average Co-Inventor Count = 5.64
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (11 from 4,770 patents)
2. Merck Sharp + Dohme Corp. (9 from 2,405 patents)
3. Merck Canada Inc. (3 from 40 patents)
20 patents:
1. 10189831 - Non-nucleoside reverse transcriptase inhibitors
2. 9822107 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
3. 9718819 - Non-nucleoside reverse transcriptase inhibitors
4. 9598405 - Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
5. 9499534 - Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
6. 8993779 - Positive allosteric modulators of MGLUR2
7. 8765784 - Positive allosteric modulators of MGLUR2
8. 8735417 - Aminopyrimidines as Syk inhibitors
9. 8551984 - Aminopyrimidines as SYK inhibitors
10. 7625912 - Mitotic kinesin inhibitors
11. 7501435 - Inhibitors of checkpoint kinases
12. 7348440 - Mitotic kinesin inhibitors
13. 7301028 - Mitotic kinesin inhibitors
14. 7186723 - Tyrosine kinase inhibitors
15. 7169788 - Tyrosine kinase inhibitors